Skip to main content

Evaluation of the efficacy of a combined regimen including an ER targeted therapy and ICB

Research Grant
Duke Scholars

Administered By

Pharmacology & Cancer Biology

Awarded By

Sermonix Pharmaceuticals

Start Date

August 21, 2023

End Date

July 31, 2024
 

Administered By

Pharmacology & Cancer Biology

Awarded By

Sermonix Pharmaceuticals

Start Date

August 21, 2023

End Date

July 31, 2024